Arnold Silva, MD, PHD

NPI: 1497790646
Total Payments
$605,251
2024 Payments
$150,454
Companies
40
Transactions
998
Medicare Patients
172
Medicare Billing
$24,492

Payment Breakdown by Category

Other$409,875 (67.7%)
Travel$104,482 (17.3%)
Consulting$62,801 (10.4%)
Food & Beverage$24,172 (4.0%)
Research$3,850 (0.6%)
Education$71.24 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $405,855 214 67.1%
Travel and Lodging $104,482 259 17.3%
Consulting Fee $62,801 58 10.4%
Food and Beverage $24,172 437 4.0%
Honoraria $4,020 1 0.7%
Unspecified $3,850 22 0.6%
Education $71.24 7 0.0%

Payments by Type

General
$601,401
976 transactions
Research
$3,850
22 transactions

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $113,579 169 $0 (2024)
AstraZeneca Pharmaceuticals LP $93,504 166 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $85,871 85 $0 (2024)
Travere Therapeutics, Inc. $57,246 128 $0 (2024)
GlaxoSmithKline, LLC. $56,256 109 $0 (2024)
Lilly USA, LLC $37,809 31 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $34,896 40 $0 (2024)
Aurinia Pharma U.S., Inc. $30,742 36 $0 (2022)
Alexion Pharmaceuticals, Inc. $27,554 19 $0 (2024)
Vifor Pharma, Inc. $19,881 27 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $150,454 191 Boehringer Ingelheim Pharmaceuticals, Inc. ($33,111)
2023 $71,308 126 Travere Therapeutics, Inc. ($26,013)
2022 $80,734 116 Bayer HealthCare Pharmaceuticals Inc. ($29,989)
2021 $102,003 134 Bayer HealthCare Pharmaceuticals Inc. ($45,192)
2020 $31,710 65 GlaxoSmithKline, LLC. ($12,300)
2019 $86,893 175 Amgen Inc. ($39,801)
2018 $63,027 111 Amgen Inc. ($53,212)
2017 $19,122 80 Amgen Inc. ($17,004)

All Payment Transactions

998 individual payment records from CMS Open Payments — Page 1 of 40

Date Company Product Nature Form Amount Type
12/20/2024 Ardelyx, Inc. Consulting Fee In-kind items and services $2,450.00 General
12/19/2024 Travere Therapeutics, Inc. Travel and Lodging Cash or cash equivalent $32.41 General
12/19/2024 Travere Therapeutics, Inc. Travel and Lodging Cash or cash equivalent $17.00 General
12/19/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $11.82 General
12/11/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $19.72 General
Category: NEPHROLOGY
12/05/2024 Travere Therapeutics, Inc. Travel and Lodging Cash or cash equivalent $445.44 General
12/05/2024 Boehringer Ingelheim International GmbH Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $178.88 General
12/05/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $51.32 General
12/05/2024 Travere Therapeutics, Inc. Travel and Lodging Cash or cash equivalent $20.00 General
12/02/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,500.00 General
12/02/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,500.00 General
12/02/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
11/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
Category: DIABETES
11/19/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $133.83 General
Category: Nephrology
11/13/2024 Travere Therapeutics, Inc. Travel and Lodging Cash or cash equivalent $588.47 General
11/13/2024 Travere Therapeutics, Inc. Travel and Lodging In-kind items and services $259.50 General
11/13/2024 Amgen Inc. Aranesp (Biological), Parsabiv, TAVNEOS Food and Beverage In-kind items and services $145.50 General
Category: Nephrology
11/13/2024 Travere Therapeutics, Inc. Travel and Lodging Cash or cash equivalent $18.00 General
11/12/2024 Lilly USA, LLC JARDIANCE (Drug) Consulting Fee Cash or cash equivalent $1,425.00 General
Category: Diabetes
11/06/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
11/06/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $960.00 General
Category: DIABETES
11/06/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $119.83 General
11/06/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $12.56 General
Category: GASTROENTEROLOGY
10/29/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Consulting Fee Cash or cash equivalent $2,500.00 General
Category: Nephrology
10/26/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $134.41 General

Research Studies & Clinical Trials

Study Name Company Amount Records
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P GlaxoSmithKline, LLC. $3,453 19
safety and efficacy linagliptin vs SU Boehringer Ingelheim b.v. $396.20 3

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 2 172 351 $64,213 $24,492
Total Patients
172
Total Services
351
Medicare Billing
$24,492
Procedure Codes
2

All Medicare Procedures & Services

2 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 121 285 $55,102 $19,029 34.5%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 51 66 $9,111 $5,463 60.0%

About Arnold Silva, MD, PHD

Arnold Silva, MD, PHD is a Internal Medicine healthcare provider based in Meridian, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497790646.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arnold Silva, MD, PHD has received a total of $605,251 in payments from pharmaceutical and medical device companies, with $150,454 received in 2024. These payments were reported across 998 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($405,855).

As a Medicare-enrolled provider, Silva has provided services to 172 Medicare beneficiaries, totaling 351 services with total Medicare billing of $24,492. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Nephrology
  • Location Meridian, ID
  • Active Since 06/19/2006
  • Last Updated 01/21/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1497790646

Products in Payments

  • Parsabiv (Biological) $109,966
  • LOKELMA (Drug) $92,894
  • Kerendia (Drug) $85,794
  • JARDIANCE (Drug) $75,905
  • LUPKYNIS (Drug) $30,742
  • JESDUVROQ (Drug) $29,033
  • Rayaldee (Drug) $11,419
  • ULTOMIRIS (Biological) $9,818
  • KORSUVA (Drug) $4,541
  • TARPEYO (Drug) $3,410
  • Parsabiv (Drug) $3,137
  • INVOKANA (Drug) $2,716
  • TRADJENTA (Drug) $396.20
  • Aranesp (Biological) $352.14
  • ENTRESTO (Drug) $309.88
  • JYNARQUE (Drug) $266.32
  • Veltassa (Drug) $205.76
  • KRYSTEXXA (Biological) $200.80
  • LEQVIO (Drug) $189.33
  • KRYSTEXXA (Drug) $175.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Meridian